A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...

Keytruda and Efti combination therapy achieved a median overall survival of 17.6 months in head and neck squamous cell carcinoma with PD-L1 CPS less than one. The combination therapy demonstrated a ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival ...

Read was diagnosed with olfactory neuroblastoma, also known as esthesioneuroblastoma, a rare head and neck cancer found in ...

3 “We are excited to see this strong survival benefit for head and neck cancer patients with such cold tumors. Combining these two complementary immunotherapies has led to a 7-fold increase in ...

HELSINKI and BOSTON, May 16, 2025 /PRNewswire/ -- Neutron Therapeutics LLC and the Helsinki University Hospital announce that they have treated the first cancer patients in a European hospital ...

Babbs is accused of forcibly entering a bedroom and stabbing the 36-year-old “several times in the head and neck,” police said. Babbs is accused of running from the home, but was found nearby ...

This article will explain whether neck pain can be a sign of cancer, along with other specific symptoms of head and neck cancer. It will also detail the causes and treatment of head and neck ...

Jacqueline Laurita gave fans a glimpse of her gory recovery after undergoing a facelift and neck lift ... was seen with bandages wrapped around her head and jaw, as well as drains filled with ...

The FDA has started a priority review of MSD's Keytruda as neoadjuvant and adjuvant treatment of locally advanced head and neck squamous cell carcinoma (HNSCC), with a decision due by 23rd June.